Scientific Program

Conference Series Ltd invites all the participants across the globe to attend International Dermatology Conference: Skin and Body Amsterdam, Netherlands.

Submit your Abstract
or e-mail to

events@conferenceseries.com
rohit.casper@memeetings.net
rohit.casper@memeetings.net

Scientific Program Day 1
Scientific Program Day 2

Day 1 :

Keynote Forum

Clemens Esche

Beautiful Skin Institute PLLC, USA

Keynote: Acne scar reduction: What is new?

Time : 09:45 - 10.45

Conference Series Skin Body 2018 International Conference Keynote Speaker Clemens Esche photo
Biography:

Clemens Esche is a board-certified dermatologist who graduated from The Johns Hopkins dermatology program and held assistant professor appointments at the University of Pittsburgh, the Mayo Clinic and at The Johns Hopkins University. Dr. Esche founded The Beautiful Skin Institute PLLC in Herndon, VA, in 2016. He has received more than 10 academic awards for his pioneering research and has authored more than 70 publications. He was recognized with the Patient’s Choice Award in 2013 and became the National Winner of the Doctor’s Choice Award in 2014 and again in 2015. Dr. Esche treats adult, pediatric and cosmetic patients and specializes in minimally invasive cosmetic procedures with little to zero downtime.

 

Abstract:

Inflammation is the single greatest reason for acne scar development. Consequently, the extent of scarring is associated with acne severity and delay in treatment. Each scar is different and therefore requires a customized approach. Acne scars are currently classified into 3 different types: ​(i) atrophic, (ii) hypertrophic and ​(iii) keloidal​. A net destruction of collagen in the dermis results in ​atrophic​ scarring. It can be further ​classified as ​ice-pick​ (narrow and deep, 60%), ​boxcar​ (1.5-4 mm wide, 25%) or ​rolling​ (​15​%). Less commonly, there is a net gain of collagen that results in ​hypertrophic​ or ​keloidal ​scars. Ice-pick (deep pit) scars are frequently the most severe, and, unfortunately, represent around 2/3 of cases. ​Fraxel or CO2 laser treatment ​have been considered the gold standard until recently​. ​However​, fractional radiofrequency and also the Chemical Reconstruction of Skin Scars (CROSS) technique tend to be superior to even the most advanced fractional laser for the treatment of ice pick and deep scarring. They also tend to work well for boxcar and deep rolling scars. Four treatments at monthly intervals will serve many patients well. ​ An added benefit is the shorter recovery time compared with Fraxel laser. TCA CROSS involves a high-strength TCA peel (50-100%) applied to the base of the scar to ablate the epithelial wall and to promote dermal remodeling. The degree of clinical improvement is proportional to the number of sessions. Hypertrophic and keloidal scars can be injected with corticosteroids, 5-fluorouracil, bleomycin or verapamil. Alternatives include silicone dressings and cryotherapy. Freezing from within with cryoshape is advocated periodically. Numerous 2017 publications challenge the cosmetic procedural delay following oral isotretinoin therapy. An algorithmic approach summarizes the updated recommendations.

 

Break: Networking and Refreshments Break with Group Photo- 10:45-11:05

Keynote Forum

Frien Refla Syarif

Sari Asih Hospital, Indonesia

Keynote: Latest insights of melasma and its newest treatment

Time : 11:05-12:05

Conference Series Skin Body 2018 International Conference Keynote Speaker Frien Refla Syarif photo
Biography:

Frien Refla Syarif has completed her MD degree from Trisakti University, Jakarta, Indonesia. She took Dermatology and Venereology Residency Program in Andalas University, Padang, Indonesia, graduated in 2016. The title of the thesis she took was about melasma. Dr. Refla has published several scientific papers in the national dermatology journal. Although in this moment is just her second year to be a Dermatologist, she has been a speaker for several times in domestic and national symposiums, and spoke about dermatology aesthetics in accordance to her passion. Dr. Refla has also been a keynote speaker several times in the national online newspaper.

 

Abstract:

Melasma is an acquired pigmentary disorder and characterized by symmetrical hyperpigmented macules and patches on the sun exposed area especially on  the face. It is one of the most common skin problem and widely occur in women. This hyperpigmentation disorder commonly occurs in Fitzpatrick skin types III to VI that can causes cosmetic disfigurement and leads to psychological problems. Its pathogenesis is not yet fully understood but the common risk factors for melasma include ultraviolet exposure, pregnancy, oral contraceptives, thyroid hormones, cosmetics, phototoxic medications, anticonvulsant drugs and genetic factor. Most recently data supported that pathogenesis of melasma involves vascular growth factors. Although various treatments are available for melasma, it remains a difficult condition to treat because pigment formation is highly complex. A wide variety of treatments include hydroquinone, tretinoin, kojic acid, azelaic acid, glycolic acid, arbutin, niacinamide, tranexamic acid, laser, broad spectrum sunscreen and sun avoidance have been suggested to be a pigmentation control agents. In recent times, platelet rich plasma (PRP) is fetching attention in aesthetic medicine with fewer side effects and could be a promising treatment options for melasma. Apart from topical treatments, oral medications are also widely developed to improve melasma and may provide as well for the treatment options for overall hyperpigmentation cases.

 

Keynote Forum

Terri Vinson

Synergie Skin, Australia

Keynote: Enviroageing: The impact of urban pollution, infrared and visible light on human skin

Time : 12:05-13:05

Conference Series Skin Body 2018 International Conference Keynote Speaker Terri Vinson photo
Biography:

Terri holds a Bachelor of Science (Immunology & Microbiology), a post-graduate Diploma of Formulating Chemistry, and a Diploma of Education (Biology & Senior Science). She is a world recognised formulator, lecturer and author in the field of cosmetic science. As the founder and formulator of Synergie Skin, Terri Vinson is dedicated to creating highly active cosmeceuticals and functionally protective mineral makeup. In accordance with her trademarked ‘Clean Science’ philosophy, she is dedicated to formulating safe and ethical products that protect, change, and nurture skin and promote long-term dermal health.

 

Abstract:

Introduction: The skin is the largest organ of the body and in constant contact with both the internal and external environment. The impact of environmental pollution and solar radiation (UV,IR and HEV) are the major contributoirs to cellular damage, free radical formation and enviroageing. Until recently the aesthetics industry has been solely focused on the harmful effecs of ultraviolet wavelenghts of radiation only. It is universally accepted that UVA and UVB protection is mandatory. However, we are now looking beyond the UV sprectum at the negative impact of infrared light and high energy visible light (in particular blue light) and the potentially damaging interaction with epidemal and dermal cells. Moreover, the impact of urban pollution is now recognised as a significant factor contributing to cellular inflammation and extrinsic ageing. This presentation investigates the impact of urban pollution and radiation beyond UV on th viability and function of human skin cells.

Discussion: (1) Dermal impact of environmental pollution (a) Discussion of cellular effects of PM2.5 and heavy metals, (b) Novel new ingredients to protect fom pollution damage, (c) Supporting In vivo and in vitro clinical data.(2) Discussion of Infrared (IR) light and effect on human cells (a) Discussion of novel new topical to comabat IR dermal damage,  (b) Supporting In vivo and in vitro clinical data. (3) Overview of UVA and UVB damage and impact on human skin cells (a) Mineral sunscreen protection, (b) Supporting in vivo data. (4) Impact of HEV (High energy visible) blue light on  deraml viability, (a) Environmental Protection from Blue light, (b) New evidence supporting the presence of light receptors in skin. (5) Protective cosmeceutical ingredients to mitigate enviroageing

Conclusion:  Science is now able to look beyond UV into enviroageing and and discover novel ingredients to combat environmentally based cellular damage and inflammation.

 

Keynote Forum

Myat Sanda Kyaw

University of Medicine 2, Myanmar

Keynote: Dermatoses in flood

Time : 11:05-12:05

Conference Series Skin Body 2018 International Conference Keynote Speaker Myat Sanda Kyaw photo
Biography:

Myat Sanda Kyaw has completed MBBS (1993), Diploma in Dermatology in Thailand (2000), M. Med. Sc (Dermatology) (2002), University of Medicine (1), Yangon and Diploma in Medical Education (2014). She is professor, Dermatology department, University of Medicine 2, Yangon, Myanmar. She was published article of Myanmar Environmental Dermatoses, 2015, 13th Asia Pacific Environmental and Occupational Dermatology Symposium and The 38th Philipine Dermatological Society Annual Convention; Psoriasis patients at Yangon General Hospital, 2016, Burma medical journal and Traditional and Ethnobotanical Dermatology Practices
in Myanmar, Clinics in Dermatology, 2018. She is professor of first Master degree course of Dermatology, University of Medicine 2, Myanmar.

Abstract:

Climate change is a cause of natural disasters posing social and public health problems. There are various skin diseases of 163 patients (71 males and 92 females) were detected in post-flood medical tour (August and September, 2016) of Kyone Pyaw and Zalun of Ayerwady Division, flooded areas in June and August, 2016. The skin conditions were classified into two groups, itchy (85.2 %) and non- itchy (14.7 %) dermatoses. 142 patients were > 12 years old and 21 patients were < 12 years, the youngest was 2 and a half months and the eldest was 75 years. The most common flooded related itchy dermatosis was urticaria (12.3 %). It was followed by contact dermatitis (7.9 %), insect bite reaction (4.3 %) and photodermatitis (2.5 %). The flooded aggravated itchy dermatosis were tinea infection (25 .8 %), eczema (25.63 %), scabies (2.5 %), fixed drug eruption (1.8 %), psoriasis (1.22 %), pityriasis versicolor (0.6%) and pityriasis rosea (0.6 %). Non - itchy dermatoses were vitiligo (4.3 %), acne, impetigo and cutaneous amyloidosis (1.22 % in each); fish bone trauma, senile purpura, acrocordon, syringoma,
mole, melasma, hypertrophic scar, systemic lupus erythematosus, neurofibromatosis type 1, and molluscum contagiosum and Hensen’s disease (0.6 % each). In this study, itchy dermatoses markedly exceed non - itchy dermatoses. Urticaria and contact dermatitis were at the top of itchiness during and after flood. The posssible causes of itchiness for urticaria, contact dermatitis and preexisting dermatoses were fertilizers and contaminants in the flood water.

  • Cosmetic Dermatology | Dermatological Diseases | Immune System Diseases | Dermato-Oncology | Bariatric Surgery | Hair Transplant Surgery | Cosmetics and Skin Care | Cosmetic Dentistry | Cosmeceuticals | Natural Approach to Hair and Skin
Location: Bali, Indonesia
Speaker

Chair

Ornkes Panyanetinad

Bangpakok 9 International Hospital, Thailand

Session Introduction

Myat Sanda Kyaw

University of Medicine 2, Myanmar

Title: Dermatoses in flood

Time : 14:05-14:35

Speaker
Biography:

Myat Sanda Kyaw has completed MBBS (1993), Diploma in Dermatology in Thailand (2000), M. Med. Sc (Dermatology) (2002), University of Medicine (1), Yangon and Diploma in Medical Education (2014). She is professor, Dermatology department, University of Medicine 2, Yangon, Myanmar. She was published article of Myanmar Environmental Dermatoses, 2015, 13th Asia Pacific Environmental and Occupational Dermatology Symposium and The 38th Philipine Dermatological Society Annual Convention; Psoriasis patients at Yangon General Hospital, 2016, Burma medical journal and Traditional and Ethnobotanical Dermatology Practices in Myanmar, Clinics in Dermatology, 2018. She is professor of first Master degree course of Dermatology, University of Medicine 2, Myanmar.

Abstract:

Climate change is a cause of natural disasters posing social and public health problems. There are various skin diseases of 163 patients (71 males and 92 females) were detected in post-flood medical tour (August and September, 2016) of Kyone Pyaw and Zalun of Ayerwady Division, flooded areas in June and August, 2016. The skin conditions were classified into two groups, itchy (85.2 %) and non- itchy (14.7 %) dermatoses. 142 patients were > 12 years old and 21 patients were < 12 years, the youngest was 2 and a half months and the eldest was 75 years. The most common flooded related itchy dermatosis was urticaria (12.3 %). It was followed by contact dermatitis (7.9 %), insect bite reaction (4.3 %) and photodermatitis (2.5 %). The flooded aggravated itchy dermatosis were tinea infection (25 .8 %), eczema (25.63 %), scabies (2.5 %), fixed drug eruption (1.8 %), psoriasis (1.22 %), pityriasis versicolor (0.6%) and pityriasis rosea (0.6 %). Non - itchy dermatoses were vitiligo (4.3%), acne, impetigo and cutaneous amyloidosis (1.22 % in each); fish bone trauma, senile purpura, acrocordon, syringoma, mole, melasma, hypertrophic scar, systemic lupus erythematosus, neurofibromatosis type 1, and molluscum contagiosum and Hensen’s disease (0.6 % each). In this study, itchy dermatoses markedly exceed non - itchy dermatoses. Urticaria and contact dermatitis were at the top of itchiness during and after flood. The possible causes of itchiness for urticaria, contact dermatitis and preexisting dermatoses were fertilizers and contaminants in the flood water.

Azhar Bahhaeddin Al Rakkad

VIA Center, Saudi Arabia

Title: Periorbital pigmentation treated by fat transfer with or without PRP

Time : 14:35-15:05

Speaker
Biography:

Azhar Bahhaeddin completed master degree in dermatology – Damascus University in 2011. She also completed her Arab Board Certificate in Dermatology – Demascus University in 2013 and American Board of Aesthetic Medicine at Dubai in 2016. She is a member of American Saudi Dermatology Association, American Association of Aesthetic Medicine and ASDS.

Abstract:

Abstract: Periorbital pigmentation as a cosmetic problem
• It is a very common complain in Asians
• More than 50% of my patients have this complain
 
Causes:
• 1-Genetics
• 2-Familial
• 3-External: Sun exposure
• 4-Related issues: thyroid disease, atopic dermatitis, liver, and kidney
• 5-Life style: smoking, drinking water, sleeping hours
 
Treatment options:
• Creams
• Carboxy therapy
• Fillers injection
• Lights or lasers
 
Fat transfer with or without PRP:
• All are temporary and mostly disappointing. Fat as a treatment option
• Natural
• Long lasting
• Less side effect

Ornkes Panyanetinad

Bangpakok 9 International Hospital, Thailand

Title: New era of non-invasive female genitalia rejuvenation in skin of color by Fractional Erbium Yag
Speaker
Biography:

Ornkes Panyanetinad accomplished her 1st class honored medical degree from Chulalongkorn University. She furthered her study as the youngest graduated diploma of dermatology from Ramathibodhi hospital. Dr. Ornkes was invited to be the advisory board and keynote speaker for advanced level training of various international companies and courses to train the advanced uses of filler, botox, and thread lift, and invited to be the speaker for holistic anti-aging, cellular and nutrition therapy. With her extensive experience, Dr. Ornkes has invented her own technique “Blunt en bloc”,“crepe cake layering technique”, and “GFAn – Global facial analysis with natural look injection technique” for more scrupulous filler injection, facial asymmetry correction and focused on natural-looked botulinum Page 1 of 3 toxin injection technique.

Abstract:

Intimate areas are now the new playing zone in the aesthetic market. For intravaginal treatment, fractional erbium laser has a well-established role in treating urinary symptoms altogether with increasing vaginal wall thickness, lubrication, sexual intercourse satisfaction and reducing symptoms from atrophic vagina. However, for external genitalia with denser pigmentation, the concern is for athe post procedural hyperpigmentation that can happen post erbium laser treatment. We have carried out the first external genitalia rejuvenation with fractional erbium MCL clinical study trial in Fitzpatrick skin
type IV-V. The results are impressive and most of the cases are satisfied with the results. There are significant improvements in genital fullness, firmness, skin lightening, GAIS improvement, or even sexual intercourse satisfaction. Pain is tolerable with regular topical EMLA cream. Every case can resume daily life activity immediately after the treatment and normal sexual activity within 72 hours. Healing period speed relies on each case’s post operative compliance and health status. In conclusion, fractional erbium MCL is safe and effective way for intimate area rejuvenation with standardized treatment protocol.

Amrit Kaur

Government Medical College and Hospital, India

Title: To assess the clinical efficacy of topical tranexamic acid with microneedling in melasma: A split face study
Speaker
Biography:

Kaur A has completed her MBBS at the age of 24 years from Government Medical College And Hospital, Chandigarh (UT), INDIA. She is currently pursuing her post graduation junior residency i.e. MD dermatology, venereology and leprosy from Government Medical College And Hospital, Chandigarh (UT), INDIA. She has 2 case reports that are under publications. She has presented around 5 posters and 2 oral presentations in different national conferences.

Abstract:

Introduction: Melasma is a common cause of facial hyperpigmentation, which is recurrent and refractory resulting in cosmetic disfigurement and adversely affects the quality of life. Although several treatment modalities are available, none is satisfactory.
 
Objective: To assess the clinical efficacy and adverse effects of topical tranexamic acid with micro needling in melasma.
 
Material and Method: This is a split face, prospective, randomized, open‑label study with a sample size of 40. The left or right side of the face was chosen randomly and micro needling was done on both the sides, followed by 10% tranexamic acid (TA) solution on one side of the face (test side) and distilled water on the other side of the face (control). The procedure was done at 2 weekly intervals (0, 2, 4 and 6 weeks). Clinical images were taken at each visit including modified Melasma Area Severity Index (MASI) scoring of each half of the face to assess the clinical response. Patient satisfaction scores and side effects were also noted.
 
Result: On the test side, there was 65.92% improvement in the mean MASI score compared to 20.75% on the control side of the face at the end of 8 weeks. Subjective satisfaction scores on the basis of pigmentation and improvement in skin texture increased significantly on both the sides of face however the participants were more satisfied with the results of the combined therapy side than on the control side. No significant side effect of tranexamic acid (TA) solution was found.
 
Conclusion: TA can be used as potentially a new, effective, safe and promising therapeutic agent in melasma with and is more efficacious when used along with micro needling.

Ankita Tuknayat

Government Medical College and Hospital, India

Title: Clinical efficacy of intralesional platelet rich plasma in melasma
Speaker
Biography:

Ankita Tuknayat is pursuing her post graduate residency in Dermatology in Government Medical College and Hospital, Chandigarh, India. She has 2 international publications namely Cyclophosphamide Induced Hearing loss – Reversibility and Preventive strategies in American Journal of Therapeutics and Extensive Donor Site Keloids in Follicular Unit Extraction Hair Transplantation in International Journal of Trichology. She has presented various papers as Speaker and multiple posters in various dermatology conferences across India. She has also won a second award in a poster presentation in a national conference on Dermatophytosis conducted in Post Graduate Institute of Medical Education and Research in 2017. She is an avid participant in various activities of Chandigarh Dermatology Society. She is very ambitious when it comes to learning and adding her research inputs towards medical literature.

 

Abstract:

Background: Melasma is a cutaneous disorder causing profound psychological morbidity. Though the exact etiopathogenesis is unknown, factors like genetic predisposition, female sex hormones and ultraviolet radiation have been implicated. Multiple therapeutic agents are available but none give clinically significant results. Thus, a need for new effective therapies arises. Platelet rich plasma (PRP) derived from the patient’s own blood has shown promising results. It contains platelet α-granules having more than 30 bioactive substances like platelet-derived growth factor (PDGF) and transforming growth factor (TGF) which decrease melanogenesis via delayed extracellular signal-regulated kinase activation. PDGF further aids in the synthesis of collagen and hyaluronic acid which is responsible for skin rejuvenation. There are no studies of PRP in Indian patients of melasma.
 
Patients and method: This is an open labeled therapeutic trial performed at Government Medical College, Chandigarh, India from January 2017 to April 2018. Forty patients were recruited. The treatment consisted of three sessions of autologous PRP injections intralesionally 1 month apart. Therapeutic outcomes were assessed by standardized digital photography and modified melasma area severity index (mMASI).
 
Result: Final results after 6 months: 3 patients (7.5%)- excellent response (>75 % reduction in mMASI), 8 patients (20%) -good improvement (51-75% reduction in mMASI), 13 patients (32.5%)- partial to fair improvement (26 – 50 % reduction in mMASI), 14 patients (35%) minimal or poor response (0-25% reduction in mMASI). There was 54.3 % reduction in mean mMASI which was statistically significant. All patients experienced significant improvement in skin texture. Patients reported improvement in acne scars and topical steroid induced hypertrichosis. There was no relapse at 6 months. Xerosis was observed in 35 % of the patients. One patient developed post inflammatory hyperpigmentation. Conclusion- PRP is a useful therapeutic approach for melasma and further studies are required to validate its efficacy.

 

Tejasswini R

JSS College of Pharmacy Campus, India

Title: Cosmetic skincare VS cosmeceuticals - Why to choose cosmeceuticals ?
Speaker
Biography:

Tejasswini R has completed her bachelor degree in pharmacy (B. Pharm) at the age of 21 years from Dr. MGR Medical University, Chennai, Tamilnadu and currently pursuing Masters in Cosmeceutics in JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru, Karnataka.

Abstract:

The global trend in the cosmetic industry towards developing ‘medicinally’ active cosmetics, and in the pharmaceutical industry towards ‘cosmetically’ oriented medicinal products. All cosmeceuticals claim to contain functional ingredients with either therapeutic, disease-fighting or healing properties. It provides external aesthetic benefits, the additional medicinal properties of cosmeceuticals are based on molecular structure, biological function relationships, and modes of action related to healing, anti-aging, free radical rampage reduction, dead epidermal cell exfoliation, and so on. In cosmeceuticals the importance to know the interaction between skin and cosmeceuticals which could even be influenced by environmental fact. Online
reviews and beauty blogs have created a community of peer reviewers that we encourages trust in Beauty Brand’s. The science of it all remains extremely crucial in making informed decisions for your skin. More than just Cosmetics, "Cosmeceuticals" is a term that every beauty junkie should learn more about this 2018. This study paper speaks about the science behind cosmeceuticals and how to make informed decisions when choosing beauty products. Today’s Cosmeceuticals are serving as a bridge between personal care products and pharmaceuticals; There is no regulatory category for Cosmeceuticals; hence this review tries to understand regulatory scenario as well the difference between drug and cosmetics is enlightened. The paper is an earnest endeavour to evaluate a Cosmeceutical product that claims a beneficial physiologic effect. This review paper is to give recent knowledge about the latest trend of cosmetic industry New challenges will also be presented to government regulatory agencies as more chemicals with true biological activity are invented and tested.

Tejasswini R

JSS College of Pharmacy Campus, India

Title: Cosmetic skincare VS cosmeceuticals - Why to choose cosmeceuticals ?
Speaker
Biography:

Tejasswini R has completed her bachelor degree in pharmacy (B. Pharm) at the age of 21 years from Dr. MGR Medical University, Chennai, Tamilnadu and currently pursuing Masters in Cosmeceutics in JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru, Karnataka.

Abstract:

The global trend in the cosmetic industry towards developing ‘medicinally’ active cosmetics, and in the pharmaceutical industry towards ‘cosmetically’ oriented medicinal products. All cosmeceuticals claim to contain functional ingredients with either therapeutic, disease-fighting or healing properties. It provides external aesthetic benefits, the additional medicinal properties of cosmeceuticals are based on molecular structure, biological function relationships, and modes of action related to healing, anti-aging, free radical rampage reduction, dead epidermal cell exfoliation, and so on. In cosmeceuticals the importance to know the interaction between skin and cosmeceuticals which could even be influenced by environmental fact. Online
reviews and beauty blogs have created a community of peer reviewers that we encourages trust in Beauty Brand’s. The science of it all remains extremely crucial in making informed decisions for your skin. More than just Cosmetics, "Cosmeceuticals" is a term that every beauty junkie should learn more about this 2018. This study paper speaks about the science behind cosmeceuticals and how to make informed decisions when choosing beauty products. Today’s Cosmeceuticals are serving as a bridge between personal care products and pharmaceuticals; There is no regulatory category for Cosmeceuticals; hence this review tries to understand regulatory scenario as well the difference between drug and cosmetics is enlightened. The paper is an earnest endeavour to evaluate a Cosmeceutical product that claims a beneficial physiologic effect. This review paper is to give recent knowledge about the latest trend of cosmetic industry New challenges will also be presented to government regulatory agencies as more chemicals with true biological activity are invented and tested.